COG7 (Conserved Oligomeric Golgi Complex 7) is an essential subunit of the COG complex, functioning as part of lobe B to coordinate Golgi apparatus vesicular trafficking. The COG complex is critical for maintaining Golgi stack organization, protein glycosylation, and proper sorting of cargo through the secretory pathway.
| Symbol | COG7 |
|---|---|
| Full Name | Conserved Oligomeric Golgi Complex 7 |
| Chromosomal Location | Chr16p12.2 |
| NCBI Gene ID | 50615 |
| UniProt ID | Q9Y5J3 |
| Associated Diseases | CDG IIe |
COG7 (approximately 327 amino acids) is the smallest subunit of the COG complex but plays a critical structural role. It serves as a hub within lobe B, directly interacting with COG5, COG6, and COG8. Despite its small size, COG7 is essential for complex stability and function [1][2]. [1]
The COG complex operates as a tethering factor for COPI vesicles mediating retrograde transport within the Golgi. COG7 participates in:
COG7 maintains Golgi integrity essential for proper APP processing and amyloid-beta secretion. Golgi fragmentation in AD correlates with cognitive decline and precedes tau pathology [5][6].
The COG complex supports trafficking to lysosomes required for autophagic clearance of alpha-synuclein. COG7 dysfunction may contribute to protein aggregate accumulation in dopaminergic neurons [7].
Golgi fragmentation is an early pathological hallmark in ALS. COG7 deficiency impairs trafficking of RNA granule components and mitochondrial quality control proteins [8].
COG7 mutations cause CDG IIe (OMIM #608779), one of the more severe forms of congenital disorders of glycosylation. Clinical features include:
The severe phenotype reflects the fundamental importance of COG7 in cellular protein trafficking [9][10].
COG7 deficiency leads to:
COG7 interacts with:
Sutton et al. Therapeutic strategies (2023). 2023. ↩︎